CN Stock MarketDetailed Quotes

Harbin Gloria Pharmaceuticals (002437)

Watchlist
  • 3.15
  • -0.06-1.87%
Market Closed May 15 15:00 CST
7.02BMarket Cap17.03P/E (TTM)

Harbin Gloria Pharmaceuticals (002437) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
-2.20%539.11M
-12.51%2.14B
-10.36%1.66B
-9.97%1.1B
-7.06%551.26M
-7.06%2.44B
-9.48%1.86B
-14.75%1.22B
-12.92%593.13M
-15.51%2.63B
Operating revenue
-2.20%539.11M
-12.51%2.14B
-10.36%1.66B
-9.97%1.1B
-7.06%551.26M
-7.06%2.44B
-9.48%1.86B
-14.75%1.22B
-12.92%593.13M
-15.51%2.63B
Other operating revenue
----
-12.77%4.38M
----
-1.75%2.46M
----
-28.39%5.02M
----
-31.73%2.5M
----
37.80%7.02M
Total operating cost
-6.01%463.88M
-14.09%1.91B
-13.21%1.46B
-11.77%977.87M
-10.81%493.55M
-10.87%2.22B
-12.93%1.69B
-17.29%1.11B
-13.04%553.36M
-18.28%2.49B
Operating cost
4.17%293.39M
2.74%1.17B
2.73%892.12M
3.22%579.51M
2.80%281.64M
3.95%1.14B
3.18%868.4M
-4.55%561.41M
-4.70%273.97M
-18.38%1.09B
Operating tax surcharges
-5.25%8.23M
-2.54%32.95M
-0.34%25.19M
-3.69%16.45M
23.16%8.69M
-6.40%33.81M
-10.57%25.27M
-13.87%17.08M
-18.85%7.06M
-13.00%36.12M
Operating expense
-19.86%127.22M
-37.39%496.29M
-34.88%411.4M
-31.28%294.24M
-27.63%158.75M
-25.82%792.65M
-26.92%631.72M
-28.03%428.16M
-20.72%219.37M
-18.15%1.07B
Administration expense
-22.28%22.69M
-20.94%131.8M
-21.95%85.87M
-21.58%56.75M
-20.97%29.19M
-4.85%166.7M
-4.94%110.02M
-7.06%72.37M
8.56%36.94M
-17.68%175.19M
Financial expense
232.37%773.52K
68.11%-340.51K
-122.81%-528.42K
-48.03%601.28K
-82.43%232.73K
-103.41%-1.07M
-91.31%2.32M
-94.83%1.16M
-91.44%1.32M
-33.02%31.31M
-Interest expense (Financial expense)
569.77%916.35K
-74.74%2.48M
-79.44%1.8M
-69.77%2.34M
-97.39%136.81K
-76.98%9.82M
-74.72%8.73M
-70.08%7.74M
-64.48%5.24M
-37.88%42.65M
-Interest Income (Financial expense)
2.01%-1.39M
48.84%-5.1M
52.80%-3.72M
59.01%-2.55M
63.06%-1.42M
46.09%-9.96M
43.35%-7.89M
31.13%-6.21M
18.73%-3.83M
11.09%-18.47M
Research and development
-23.10%11.57M
-13.62%78.43M
1.97%49.71M
7.87%30.32M
2.32%15.05M
6.27%90.79M
-19.19%48.76M
-23.61%28.1M
5.06%14.7M
-15.10%85.44M
Credit Impairment Loss
-145.99%-34.97K
-98.14%26.33K
-98.66%16.22K
-100.53%-4.54K
-85.77%76.05K
-31.23%1.42M
-23.68%1.21M
-67.84%863.83K
-57.02%534.39K
-75.86%2.06M
Asset Impairment Loss
-54.00%-405.38K
-111.23%-10.28M
-58.97%-930.38K
-54.84%-906.21K
---263.23K
-47.30%-4.87M
-19.39%-585.24K
-375.96%-585.24K
----
96.77%-3.3M
Other net revenue
181.97%32.05M
179.20%175.66M
24.85%64.02M
-24.84%30.24M
-60.37%11.37M
64.27%62.92M
-64.74%51.28M
197.41%40.23M
328.00%28.68M
111.53%38.3M
Fair value change income
395.43%17.63M
142.76%5.98M
837.75%37.69M
178.70%8.56M
131.21%3.56M
22.05%-13.98M
69.20%-5.11M
20.44%-10.88M
-524.84%-11.41M
27.54%-17.93M
Invest income
133.45%435.99K
2,499.99%136.53M
-109.44%-565.42K
-97.09%175.17K
-72.82%186.76K
122.40%5.25M
-93.57%5.99M
113.64%6.03M
103.31%687.18K
90.43%-23.44M
-Including: Investment income associates
63.38%-54.7K
52,122.48%130.79M
-433.44%-1.62M
-227.28%-668.93K
-121.73%-149.34K
98.98%-251.41K
-99.47%485.46K
101.16%525.56K
103.28%687.18K
89.95%-24.76M
Asset deal income
228.17%11.16M
4.33%3.54M
131.35%3.67M
22,354.98%3.66M
--3.4M
19.60%3.4M
221.92%1.59M
-103.11%-16.45K
----
-25.71%2.84M
Other revenue
-26.04%3.26M
-44.39%39.87M
-49.92%24.13M
-58.15%18.76M
-88.66%4.41M
-8.17%71.7M
-28.35%48.19M
232.79%44.82M
355.03%38.86M
183.66%78.08M
Operating profit
55.31%107.27M
42.15%404.91M
19.32%265.25M
-0.91%151.87M
0.91%69.07M
62.73%284.85M
-14.63%222.3M
198.35%153.27M
112.47%68.45M
164.81%175.05M
Add:Non operating Income
-82.03%7.98K
420.62%6.33M
4,725.47%5M
541.55%458.67K
49.36%44.42K
-54.30%1.22M
-82.83%103.54K
-81.06%71.49K
-14.65%29.74K
53.73%2.66M
Less:Non operating expense
-10.32%146.93K
-31.65%1.62M
164.52%916.97K
-9.43%243.05K
151.13%163.83K
155.76%2.38M
-57.46%346.65K
-27.10%268.34K
-72.54%65.24K
-29.81%929.3K
Total profit
55.37%107.13M
44.39%409.62M
21.29%269.33M
-0.64%152.09M
0.78%68.95M
60.48%283.69M
-14.66%222.06M
197.91%153.07M
113.70%68.41M
165.55%176.78M
Less:Income tax cost
49.07%10.46M
-33.76%27.26M
-29.27%21.41M
-31.93%14.66M
-44.53%7.02M
-14.40%41.15M
3.89%30.27M
12.81%21.54M
24.74%12.65M
142.34%48.08M
Net profit
56.09%96.67M
57.65%382.36M
29.27%247.92M
4.48%137.42M
11.07%61.93M
88.45%242.54M
-17.00%191.79M
307.41%131.53M
154.96%55.76M
144.45%128.7M
Net profit from continuing operation
56.09%96.67M
57.65%382.36M
29.27%247.92M
4.48%137.42M
11.07%61.93M
88.45%242.54M
-17.00%191.79M
307.41%131.53M
154.96%55.76M
144.45%128.7M
Less:Minority Profit
3.68%1.74M
-44.26%5.45M
-49.88%4.16M
-54.20%3M
-51.72%1.68M
16.90%9.78M
11.60%8.3M
62.49%6.56M
91.97%3.48M
361.95%8.37M
Net profit of parent company owners
57.55%94.93M
61.93%376.91M
32.85%243.76M
7.56%134.42M
15.24%60.25M
93.43%232.76M
-17.95%183.49M
342.39%124.97M
160.65%52.28M
141.31%120.33M
Earning per share
Basic earning per share
58.03%0.0433
62.32%0.1719
33.05%0.1111
10.25%0.0613
16.60%0.0274
93.60%0.1059
-17.90%0.0835
331.01%0.0556
158.24%0.0235
141.28%0.0547
Diluted earning per share
59.77%0.0425
63.85%0.1686
29.70%0.1083
7.19%0.0596
13.19%0.0266
88.12%0.1029
-17.90%0.0835
331.01%0.0556
158.24%0.0235
141.28%0.0547
Other composite income
-3,677.72%-1.53M
-330.38%-1.1M
-64.74%-639.69K
-170.64%-159.25K
-156.82%-40.53K
-44.22%477K
-128.52%-388.3K
-86.26%225.43K
109.99%71.33K
-82.97%855.1K
Other composite income of parent company owners
-3,677.72%-1.53M
-330.38%-1.1M
-64.74%-639.69K
-170.64%-159.25K
-156.82%-40.53K
-44.22%477K
-128.52%-388.3K
-86.26%225.43K
109.99%71.33K
-82.97%855.1K
Total composite income
53.72%95.14M
56.89%381.26M
29.20%247.28M
4.18%137.26M
10.85%61.89M
87.58%243.02M
-17.65%191.4M
288.38%131.75M
163.90%55.83M
145.54%129.56M
Total composite income of parent company owners
55.11%93.4M
61.13%375.81M
32.78%243.12M
7.24%134.26M
15.01%60.21M
92.46%233.24M
-18.62%183.1M
318.87%125.2M
170.64%52.35M
142.33%121.19M
Total composite income of minority owners
3.68%1.74M
-44.26%5.45M
-49.88%4.16M
-54.20%3M
-51.72%1.68M
16.90%9.78M
11.60%8.3M
62.49%6.56M
91.97%3.48M
361.95%8.37M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Accounting Firm for the Meeting (Special General Partnership)
--
--
--
Accounting Firm for the Meeting (Special General Partnership)
--
--
--
Accounting Firm for the Meeting (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue -2.20%539.11M-12.51%2.14B-10.36%1.66B-9.97%1.1B-7.06%551.26M-7.06%2.44B-9.48%1.86B-14.75%1.22B-12.92%593.13M-15.51%2.63B
Operating revenue -2.20%539.11M-12.51%2.14B-10.36%1.66B-9.97%1.1B-7.06%551.26M-7.06%2.44B-9.48%1.86B-14.75%1.22B-12.92%593.13M-15.51%2.63B
Other operating revenue -----12.77%4.38M-----1.75%2.46M-----28.39%5.02M-----31.73%2.5M----37.80%7.02M
Total operating cost -6.01%463.88M-14.09%1.91B-13.21%1.46B-11.77%977.87M-10.81%493.55M-10.87%2.22B-12.93%1.69B-17.29%1.11B-13.04%553.36M-18.28%2.49B
Operating cost 4.17%293.39M2.74%1.17B2.73%892.12M3.22%579.51M2.80%281.64M3.95%1.14B3.18%868.4M-4.55%561.41M-4.70%273.97M-18.38%1.09B
Operating tax surcharges -5.25%8.23M-2.54%32.95M-0.34%25.19M-3.69%16.45M23.16%8.69M-6.40%33.81M-10.57%25.27M-13.87%17.08M-18.85%7.06M-13.00%36.12M
Operating expense -19.86%127.22M-37.39%496.29M-34.88%411.4M-31.28%294.24M-27.63%158.75M-25.82%792.65M-26.92%631.72M-28.03%428.16M-20.72%219.37M-18.15%1.07B
Administration expense -22.28%22.69M-20.94%131.8M-21.95%85.87M-21.58%56.75M-20.97%29.19M-4.85%166.7M-4.94%110.02M-7.06%72.37M8.56%36.94M-17.68%175.19M
Financial expense 232.37%773.52K68.11%-340.51K-122.81%-528.42K-48.03%601.28K-82.43%232.73K-103.41%-1.07M-91.31%2.32M-94.83%1.16M-91.44%1.32M-33.02%31.31M
-Interest expense (Financial expense) 569.77%916.35K-74.74%2.48M-79.44%1.8M-69.77%2.34M-97.39%136.81K-76.98%9.82M-74.72%8.73M-70.08%7.74M-64.48%5.24M-37.88%42.65M
-Interest Income (Financial expense) 2.01%-1.39M48.84%-5.1M52.80%-3.72M59.01%-2.55M63.06%-1.42M46.09%-9.96M43.35%-7.89M31.13%-6.21M18.73%-3.83M11.09%-18.47M
Research and development -23.10%11.57M-13.62%78.43M1.97%49.71M7.87%30.32M2.32%15.05M6.27%90.79M-19.19%48.76M-23.61%28.1M5.06%14.7M-15.10%85.44M
Credit Impairment Loss -145.99%-34.97K-98.14%26.33K-98.66%16.22K-100.53%-4.54K-85.77%76.05K-31.23%1.42M-23.68%1.21M-67.84%863.83K-57.02%534.39K-75.86%2.06M
Asset Impairment Loss -54.00%-405.38K-111.23%-10.28M-58.97%-930.38K-54.84%-906.21K---263.23K-47.30%-4.87M-19.39%-585.24K-375.96%-585.24K----96.77%-3.3M
Other net revenue 181.97%32.05M179.20%175.66M24.85%64.02M-24.84%30.24M-60.37%11.37M64.27%62.92M-64.74%51.28M197.41%40.23M328.00%28.68M111.53%38.3M
Fair value change income 395.43%17.63M142.76%5.98M837.75%37.69M178.70%8.56M131.21%3.56M22.05%-13.98M69.20%-5.11M20.44%-10.88M-524.84%-11.41M27.54%-17.93M
Invest income 133.45%435.99K2,499.99%136.53M-109.44%-565.42K-97.09%175.17K-72.82%186.76K122.40%5.25M-93.57%5.99M113.64%6.03M103.31%687.18K90.43%-23.44M
-Including: Investment income associates 63.38%-54.7K52,122.48%130.79M-433.44%-1.62M-227.28%-668.93K-121.73%-149.34K98.98%-251.41K-99.47%485.46K101.16%525.56K103.28%687.18K89.95%-24.76M
Asset deal income 228.17%11.16M4.33%3.54M131.35%3.67M22,354.98%3.66M--3.4M19.60%3.4M221.92%1.59M-103.11%-16.45K-----25.71%2.84M
Other revenue -26.04%3.26M-44.39%39.87M-49.92%24.13M-58.15%18.76M-88.66%4.41M-8.17%71.7M-28.35%48.19M232.79%44.82M355.03%38.86M183.66%78.08M
Operating profit 55.31%107.27M42.15%404.91M19.32%265.25M-0.91%151.87M0.91%69.07M62.73%284.85M-14.63%222.3M198.35%153.27M112.47%68.45M164.81%175.05M
Add:Non operating Income -82.03%7.98K420.62%6.33M4,725.47%5M541.55%458.67K49.36%44.42K-54.30%1.22M-82.83%103.54K-81.06%71.49K-14.65%29.74K53.73%2.66M
Less:Non operating expense -10.32%146.93K-31.65%1.62M164.52%916.97K-9.43%243.05K151.13%163.83K155.76%2.38M-57.46%346.65K-27.10%268.34K-72.54%65.24K-29.81%929.3K
Total profit 55.37%107.13M44.39%409.62M21.29%269.33M-0.64%152.09M0.78%68.95M60.48%283.69M-14.66%222.06M197.91%153.07M113.70%68.41M165.55%176.78M
Less:Income tax cost 49.07%10.46M-33.76%27.26M-29.27%21.41M-31.93%14.66M-44.53%7.02M-14.40%41.15M3.89%30.27M12.81%21.54M24.74%12.65M142.34%48.08M
Net profit 56.09%96.67M57.65%382.36M29.27%247.92M4.48%137.42M11.07%61.93M88.45%242.54M-17.00%191.79M307.41%131.53M154.96%55.76M144.45%128.7M
Net profit from continuing operation 56.09%96.67M57.65%382.36M29.27%247.92M4.48%137.42M11.07%61.93M88.45%242.54M-17.00%191.79M307.41%131.53M154.96%55.76M144.45%128.7M
Less:Minority Profit 3.68%1.74M-44.26%5.45M-49.88%4.16M-54.20%3M-51.72%1.68M16.90%9.78M11.60%8.3M62.49%6.56M91.97%3.48M361.95%8.37M
Net profit of parent company owners 57.55%94.93M61.93%376.91M32.85%243.76M7.56%134.42M15.24%60.25M93.43%232.76M-17.95%183.49M342.39%124.97M160.65%52.28M141.31%120.33M
Earning per share
Basic earning per share 58.03%0.043362.32%0.171933.05%0.111110.25%0.061316.60%0.027493.60%0.1059-17.90%0.0835331.01%0.0556158.24%0.0235141.28%0.0547
Diluted earning per share 59.77%0.042563.85%0.168629.70%0.10837.19%0.059613.19%0.026688.12%0.1029-17.90%0.0835331.01%0.0556158.24%0.0235141.28%0.0547
Other composite income -3,677.72%-1.53M-330.38%-1.1M-64.74%-639.69K-170.64%-159.25K-156.82%-40.53K-44.22%477K-128.52%-388.3K-86.26%225.43K109.99%71.33K-82.97%855.1K
Other composite income of parent company owners -3,677.72%-1.53M-330.38%-1.1M-64.74%-639.69K-170.64%-159.25K-156.82%-40.53K-44.22%477K-128.52%-388.3K-86.26%225.43K109.99%71.33K-82.97%855.1K
Total composite income 53.72%95.14M56.89%381.26M29.20%247.28M4.18%137.26M10.85%61.89M87.58%243.02M-17.65%191.4M288.38%131.75M163.90%55.83M145.54%129.56M
Total composite income of parent company owners 55.11%93.4M61.13%375.81M32.78%243.12M7.24%134.26M15.01%60.21M92.46%233.24M-18.62%183.1M318.87%125.2M170.64%52.35M142.33%121.19M
Total composite income of minority owners 3.68%1.74M-44.26%5.45M-49.88%4.16M-54.20%3M-51.72%1.68M16.90%9.78M11.60%8.3M62.49%6.56M91.97%3.48M361.95%8.37M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Accounting Firm for the Meeting (Special General Partnership)------Accounting Firm for the Meeting (Special General Partnership)------Accounting Firm for the Meeting (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More